News

Back
July 29, 2020

Salarius Pharmaceuticals to Expand Clinical Program to Target Additional Sarcomas in Phase 1/2 Clinical Program

Contact

Tiberend Strategic Advisors, Inc. Johanna Bennett jbennett@tiberend.com
Download PDF